In a 76-year-old man with left ventricular ejection fraction of 48% undergoing dental extraction, what is the cardiac risk?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 14, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Cardiac Risk Assessment for Dental Extraction

This 76-year-old man with an LVEF of 48% is at INTERMEDIATE cardiac risk for dental extraction, with an estimated 90-day mortality risk approximately 1.5-fold higher than patients without heart failure, though dental extraction itself is a low-risk procedure that can be safely performed with appropriate precautions.

Risk Stratification

The patient's LVEF of 48% places him in the heart failure with reduced ejection fraction (HFrEF) category. According to the 2024 AHA/ACC perioperative guidelines, patients with heart failure have significantly elevated perioperative risk 1:

  • 90-day mortality for LVEF 40-50%: 5.11% (adjusted OR 1.53 compared to no HF)
  • This represents approximately 4-fold higher crude mortality compared to patients without heart failure
  • The adjusted odds ratio of 1.53 accounts for other comorbidities 1

Critical Context: Dental Extraction is Low-Risk

Dental extraction is NOT classified as intermediate or high-risk noncardiac surgery - it is a minor ambulatory procedure. The perioperative guidelines focus on major noncardiac surgeries, so the mortality estimates above represent worst-case scenarios for more invasive procedures 1.

Research specific to dental extraction shows:

  • Dental extraction in elderly cardiac patients is generally safe when performed with proper technique 2, 3
  • In coronary artery disease patients undergoing extraction, heart rate and blood pressure were actually LOWER than in patients without CAD, likely due to optimized medical management 4
  • Only 8% of hypertensive patients required temporary antihypertensive intervention during extraction 5

Specific Risk Factors to Monitor

Patient-specific concerns for this 76-year-old:

  • Age >70 years: Associated with higher systolic blood pressure during procedure 4
  • Reduced LVEF: While concerning for major surgery, dental extraction poses minimal hemodynamic stress
  • Cardiovascular response: Expect transient increases in heart rate and blood pressure during local anesthesia administration and extraction 4, 2

Perioperative Management Recommendations

Medication Management

Continue all guideline-directed medical therapy (GDMT) through the perioperative period 1:

  • Continue beta-blockers, ACE inhibitors/ARBs, and other HF medications
  • Exception: If on SGLT2 inhibitors, withhold 3-4 days before procedure to reduce metabolic acidosis risk 1

Procedural Precautions

Safe use of local anesthesia with vasoconstrictor:

  • Epinephrine 1:100,000 in local anesthesia does NOT increase ischemic risk when proper technique is used 3
  • Good anesthetic technique and maintained cardiac medications are key 3

Minimize procedure duration:

  • Prolonged operative time is associated with increased blood pressure fluctuations 5
  • Consider extracting fewer teeth per session if multiple extractions needed 5

Monitoring Strategy

For this patient with reduced LVEF:

  • Intraoperative ECG monitoring is reasonable given his cardiac history 2, 5
  • Monitor blood pressure and heart rate at: baseline, post-anesthesia, during extraction, and post-procedure 4
  • Holter monitoring detects more cardiovascular events than standard monitoring in high-risk elderly patients 2

Common Pitfalls to Avoid

  • Do NOT discontinue cardiac medications (except SGLT2i if applicable) - this increases risk of decompensation 1
  • Do NOT avoid epinephrine-containing anesthetics - they are safe and provide better hemostasis 3
  • Do NOT delay necessary dental treatment - untreated dental infections may pose greater cardiovascular risk than the extraction itself 6

Bottom Line

Proceed with dental extraction using standard precautions. The absolute risk is low for this minor procedure, despite his reduced LVEF. Maintain his cardiac medications, use local anesthesia with epinephrine, keep procedure time minimal, and consider intraoperative monitoring given his age and cardiac history. The risk of NOT treating dental pathology likely exceeds the procedural risk 6.

Related Questions

Can a patient taking apixaban (Eliquis) receive a local anesthetic containing epinephrine for a dental extraction?
Can a stress test be performed in a patient with a left ventricular ejection fraction of 15%?
What are normal echocardiogram (ECHO) results?
What minimum left ventricular ejection fraction is required for major non‑cardiac surgery?
How should left ventricular ejection fraction (LVEF) be assessed by ventriculography and correlated with echocardiographic measurements?
What is the recommended frequency for administering the Totilac (lactate) solution bolus in a patient with elevated intracranial pressure and an eGFR of 12 mL/min/1.73 m²?
How should a newborn with elevated postnatal prostaglandin E2 and exposure to oxytocin or carbetocin after birth with an intact umbilical cord be managed?
Can recurrent, chronic follicular lesions be considered an early stage of hidradenitis suppurativa, and does immediate treatment prevent progression to severe disease or achieve a cure?
Are disseminated painful follicular lesions with recurrent boils, abscesses, and nodules, possibly rupturing, considered the early (Hurley stage I) stage of hidradenitis suppurativa?
How should eosinophilia be evaluated and managed in a patient with IgA vasculitis (Henoch‑Schönlein purpura)?
In an adult patient with psoriatic arthritis and active axial disease who has not responded adequately to NSAIDs, how do the tumor necrosis factor‑α inhibitors (etanercept, infliximab, adalimumab, golimumab, certolizumab pegol) compare regarding efficacy, dosing convenience, and safety?

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.